DIAGNOS Announces DTC Eligibility of its Common Shares in the US

DIAGNOS (TSXV:ADK) has announced that its commons hares traded on the OTC Markets Group OTCQB Venture market under the symbol DGNOF, effective September 22 ,2017.
As quoted in the press release:

DTC is a subsidiary of the Depository Trust & Clearing Corp. and manages the electronic clearing and settlement of share transactions for publicly-traded companies.
André Larente, President of DIAGNOS, stated: “Achieving DTC eligibility will simplify trading of DIAGNOS shares on the OTCQB Venture Market and will allow U.S.-based investors and brokers to be able to fully trade our common shares on a U.S. market which will benefit DIAGNOS and all of its shareholders and is in-line with our strategy to succeed in the U.S. healthcare market for the early detection of critical health issues such as Diabetic Retinopathy and cardiovascular disease.”
The OTCQB Venture Market is for early-stage and developing U.S. and international companies that must be current in their reporting and undergo an annual verification and management certification process. DTC eligibility allows DIAGNOS shares to be more easily and economically transferred between brokerage accounts electronically within the United States. DTC is the largest securities depository in the world, providing clearing and settlement efficiencies for brokers, as well as various other services.
In addition to the OTCQB, shares of DIAGNOS continue to trade on the TSX Venture (Canada) stock exchange.

Click here to read the full press release.